Rectify

Rectifying function, Restoring hope

Cambridge, United States · Founded 2020 · $100.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Series AOct 2021
Rounds
1

About

Rectify Pharma is a clinical-stage biotech company developing Positive Functional Modulators (PFMs), a novel class of oral small-molecule therapies designed to restore and enhance membrane protein function. Its proprietary platform targets ATP-binding cassette (ABC) transporters and other membrane proteins implicated in rare genetic and common diseases. The company's lead program is focused on primary sclerosing cholangitis (PSC), with additional pipeline programs in cardio-renal-metabolic diseases and neurology.

Summary

Rectify is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $100.0M in total across 1 round, most recently a $100.0M Series A round in Oct 2021. Investors include Atlas Venture, Omega Funds and Forbion Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2021
$100.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rectify on Indexed.vc
<a href="https://indexed.vc/companies/rectify"><img src="https://indexed.vc/api/badge/company/rectify" alt="Rectify on Indexed.vc" width="260" height="76" /></a>